Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,222
datasets available to search
ShareScore release 0.9.0
Dataset results
6,222 results for “small cells”
Study of Tecemotide (L-BLP25) in Participants With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy
ClinicalTrials.gov study NCT00960115. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT01589302. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03285321. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lym
ClinicalTrials.gov study NCT00104858. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02904954. IPD Sharing: NO. Countries: 1. Publications: 3.
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00103116. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
ClinicalTrials.gov study NCT01638546. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04965090. IPD Sharing: YES. Countries: 1. Publications: 1.
Comparison of Efficacy and Safety of Tislelizumab (BGB-A317) Versus Docetaxel as Treatment in the Second- or Third-line Setting in Participants With Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03358875. IPD Sharing: YES. Countries: 10. Publications: 2.
Study to Assess the Effect of AZD9291 on the Blood Levels of Rosuvastatin, in Patients With EGFRm+ Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02317016. IPD Sharing: Not stated. Countries: 4. Publications: 1.
An Observational Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01535729. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01259089. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01454934. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
ClinicalTrials.gov study NCT02973789. IPD Sharing: UNDECIDED. Countries: 18. Publications: 10.
A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT01310036. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Safety and Efficacy of Anamorelin HCl in Patients With Non-Small Cell Lung Cancer-Cachexia (ROMANA 2)
ClinicalTrials.gov study NCT01387282. IPD Sharing: Not stated. Countries: 7. Publications: 4.
A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2)
ClinicalTrials.gov study NCT04035486. IPD Sharing: YES. Countries: 21. Publications: 7.
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
ClinicalTrials.gov study NCT04303780. IPD Sharing: YES. Countries: 23. Publications: 6.
Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00495170. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib
ClinicalTrials.gov study NCT02759835. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.